Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway

doi:10.1084/jem.144.4.970

This Article

	Full Text (PDF, 1255K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Cooper, N. R.
	Articles by Oldstone, M. B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Cooper, N. R.
	Articles by Oldstone, M. B.


Social Bookmarking

	What's this?

ARTICLES

Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway

NR Cooper, FC Jensen, RM Welsh Jr and MB Oldstone

In earlier studies we found that human serum, but not serum from multiple other species, inactivated and lysed oncornaviruses from a number of diverse sources in the apparent absence of antibody. A detailed analysis of the role of the human complement (C) system in mediating this lytic process indicates that human C1q interacts directly, in the absence of immunoglobulin, with oncornaviruses. Binding of C1 via C1q in this manner leads to activation of C1r, C1s, and thus of the classical C pathway. Integrity of the classical pathway is an absolute requirement for lysis although activation of the alternative pathway considerably amplifies the amount of lysis obtained, possibly through involvement of the C3b-dependent feedback mechanism. Activation of C is accompanied by deposition of C components on the viral surface and lysis on completion of the C reaction sequence. Thus in this system, the C1q subunit of C1 subserves a specific recognition function normally associated with antibody. This ability of human serum to inactivate oncornaviruses may represent a natural defense mechanism operative in vivo which deters expression of intact oncornaviruses in human malignancies.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Mirsaliotis, A., Nurkiyanova, K., Lamb, D., Woof, J. M., Brighty, D. W. (2007). Conformation-Specific Antibodies Targeting the Trimer-of-Hairpins Motif of the Human T-Cell Leukemia Virus Type 1 Transmembrane Glycoprotein Recognize the Viral Envelope but Fail To Neutralize Viral Entry. J. Virol. 81: 6019-6031 [Abstract] [Full Text]
Jayasekera, J. P., Moseman, E. A., Carroll, M. C. (2007). Natural Antibody and Complement Mediate Neutralization of Influenza Virus in the Absence of Prior Immunity. J. Virol. 81: 3487-3494 [Abstract] [Full Text]
Quinn, G., Wood, J. C., Ryan, D. J. J., Suling, K. M., Moran, K. M., Kolber-Simonds, D. L., Greenstein, J. L., Schuurman, H.-J., Hawley, R. J., Patience, C. (2004). Porcine Endogenous Retrovirus Transmission Characteristics of Galactose {alpha}1-3 Galactose-Deficient Pig Cells. J. Virol. 78: 5805-5811 [Abstract] [Full Text]
Favoreel, H. W., Van de Walle, G. R., Nauwynck, H. J., Pensaert, M. B. (2003). Virus complement evasion strategies. J. Gen. Virol. 84: 1-15 [Abstract] [Full Text]
Rupert, K. L., Moulds, J. M., Yang, Y., Arnett, F. C., Warren, R. W., Reveille, J. D., Myones, B. L., Blanchong, C. A., Yu, C. Y. (2002). The Molecular Basis of Complete Complement C4A and C4B Deficiencies in a Systemic Lupus Erythematosus Patient with Homozygous C4A and C4B Mutant Genes. J. Immunol. 169: 1570-1578 [Abstract] [Full Text]
Wu, T., Lee, C. G., Buckler-White, A., Kozak, C. A. (2002). Genetic Control of a Mouse Serum Lipoprotein Factor That Inactivates Murine Leukemia Viruses: Evaluation of Apolipoprotein F as a Candidate. J. Virol. 76: 2279-2286 [Abstract] [Full Text]
DePolo, N. J., Harkleroad, C. E., Bodner, M., Watt, A. T., Anderson, C. G., Greengard, J. S., Murthy, K. K., Dubensky, T. W. Jr., Jolly, D. J. (1999). The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent. J. Virol. 73: 6708-6714 [Abstract] [Full Text]
Ikeda, F., Haraguchi, Y., Jinno, A., Iino, Y., Morishita, Y., Shiraki, H., Hoshino, H. (1998). Human Complement Component C1q Inhibits the Infectivity of Cell-Free HTLV-I. J. Immunol. 161: 5712-5719 [Abstract] [Full Text]
Kojouharova, M. S., Panchev, I. D., Tchorbadjieva, M. I., Reid, K. B. M., Hoppe, H.-J. (1998). Differential Binding of IgG and of a HIV gp41 Peptide by the B Chain and A Chain Globular Head Sequences of C1q, Respectively. J. Immunol. 161: 4325-4331 [Abstract] [Full Text]
Welsh, R. M., O'Donnell, C. L., Reed, D. J., Rother, R. P. (1998). Evaluation of the Galalpha 1-3Gal Epitope as a Host Modification Factor Eliciting Natural Humoral Immunity to Enveloped Viruses. J. Virol. 72: 4650-4656 [Abstract] [Full Text]
Zajicek, J, Compston, A (1995). Mechanisms of damage and repair in multiple sclerosis -- a review. Mult Scler 1: 61-72 [Abstract]
Jamison, T. H., Cooper, N. M., Epstein, W. V. (1978). Lichen Planus and Discoid Lupus Erythematosus: Overlap Syndrome Associated With Cryoglobulinemia and Hypocomplementemia. Arch Dermatol 114: 1039-1042 [Abstract]